Idarucizumab
Product Specifications
CAS Number
1362509-93-0
Target
Thrombin
Related Pathways
Proteases/Proteasome
Bioactivity
Idarucizumab, a humanized monoclonal antibody fragment, serves as the first reversal agent for direct oral anticoagulants (DOACs) . It specifically neutralizes the effects of oral direct thrombin inhibitors, thereby restoring hemostasis [1].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6324187-01 0.2 mL
NCL, ID (P291) (NCL, Nucleolin, Protein C23) (PE)
Sign In for Pricing
View Details MBS6324187-02 5x 0.2 mL
NCL, ID (P291) (NCL, Nucleolin, Protein C23) (PE)
Sign In for Pricing
View Details 